tiprankstipranks
Trending News
More News >
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market
Advertisement

Shanghai Henlius Biotech, Inc. Class H (2696) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shanghai Henlius Biotech, Inc. Class H
HK$69.55
HK$38.94B
43.75
221.99%
5 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab Ltd
HK$22.18
HK$24.05B
-15.95%
4 Buy
1 Hold
0 Sell
Strong Buy
InnoCare Pharma Ltd.
HK$13.84
HK$21.63B
96.03%
3 Buy
1 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.06
HK$38.08B
-21.94
73.79%
2 Buy
1 Hold
1 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$12.48
HK$34.19B
33.94
76.27%
4 Buy
1 Hold
0 Sell
Strong Buy
Ascentage Pharma Group International
HK$68.05
HK$25.20B
-17.36
44.94%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2696
Shanghai Henlius Biotech, Inc. Class H
69.55
47.75
219.04%
HK:9688
Zai Lab Ltd
21.56
-3.79
-14.95%
HK:9969
InnoCare Pharma Ltd.
13.84
7.02
102.93%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.06
10.84
76.23%
HK:2096
Simcere Pharmaceutical Group Limited
12.48
5.33
74.55%
HK:6855
Ascentage Pharma Group International
68.05
22.60
49.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis